Dramatic response of aneurysmal bone cyst to denosumab: Case report and literature review

被引：5

作者：

Fadavi, Pedram ^{[1
]}

Arefpour, Amir Mohammad ^{[1
]}

Hariri, Ramyar ^{[1
]}

Vasheghani, Maryam ^{[1
]}

Garousi, Maryam ^{[1
]}

Taghizadeh-Hesary, Farzad ^{[2
]}

机构：

[1] Iran Univ Med Sci, Radiat Oncol Dept, Tehran 1449614535, Iran

[2] Shahid Beheshti Univ Med Sci, Radiat Oncol Dept, Tehran, Iran

来源：

CLINICAL CASE REPORTS | 2021年 / 9卷 / 10期

关键词：

aneurysmal bone cyst; denosumab; management; RANK ligand; resistant;

D O I：

10.1002/ccr3.4993

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Denosumab, a monoclonal antibody that specifically targets cytokine receptor activator of nuclear factor-kappa B ligand (RANKL), is a potentially viable option in resistant aneurysmal bone cysts.

引用

页数：6

共 20 条

[1] Denosumab Therapy in the Management of Aneurysmal Bone Cysts: A Comprehensive Literature Review [J].

Alhumaid, Ibrahim ;

Abu-Zaid, Ahmed .

CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (01)

[2]

Bahk WJ., 2015, AM J CLIN PATHOL, V143, P823, DOI [10.1309/ajcp33yddjkfftsv, DOI 10.1309/AJCP33YDDJKFFTSV]

[3]

Bajpai M, 2018, JCPSP-J COLL PHYSICI, V28, P174, DOI 10.29271/jcpsp.2018.02.174

[4]

Borges D., 2018, ANEURYSMAL BONE CYST

[5] Percutaneous Radionuclide Ablation of Axial Aneurysmal Bone Cysts [J].

Bush, Charles H. ;

Adler, Zachary ;

Drane, Walter E. ;

Tamurian, Robert ;

Scarborough, Mark T. ;

Gibbs, Charles P. .

AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 194 (01) :W84-W90

[6] Treatment of aneurysmal bone cysts by percutaneous CT-guided injection of calcitonin and steroid [J].

Chang, Connie Y. ;

Kattapuram, Susan V. ;

Huang, Ambrose J. ;

Simeone, F. Joseph ;

Torriani, Martin ;

Bredella, Miriam A. .

SKELETAL RADIOLOGY, 2017, 46 (01) :35-40

[7] Aneurysmal bone cyst: results of an off label treatment with Denosumab [J].

Duerr, Hans Roland ;

Grahneis, Ferdinand ;

Baur-Melnyk, Andrea ;

Knoesel, Thomas ;

Birkenmaier, Christof ;

Jansson, Volkmar ;

Klein, Alexander .

BMC MUSCULOSKELETAL DISORDERS, 2019, 20 (01)

[8]

Elsayad K, 2017, STRAHLENTHER ONKOL, V193, P332, DOI 10.1007/s00066-016-1085-6

[9]

Ghermandi R, 2016, EUR REV MED PHARMACO, V20, P3692

[10]

Hildebrand GK., 2021, STATPEARLS

← 1 2 →